BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180421
DTEND;VALUE=DATE:20180523
DTSTAMP:20260729T140642
CREATED:20180421T151417Z
LAST-MODIFIED:20180421T151521Z
UID:19914-1524268800-1527033599@ces.b2sg.org
SUMMARY:Senior Scientist III / Principal Research Scientist - Translational Oncology
DESCRIPTION:The Translational Oncology and Precision medicine group at Abbvie uses advanced methods to discover biomarkers and implement translational medicine strategies to progress Abbvie’s innovative Oncology pipeline. We are currently seeking a highly motivated individual to join our team as a Senior Scientist III to lead and oversee development and execution of Translational medicine strategy\, including companion diagnostic (CDx) development for Abbvie sponsored clinical trials. As a member of both research and clinical development project teams he/she will have the opportunity to work in a highly collaborative environment to support projects across all phases of clinical development.  \nThe key responsibilities will be:\nLead development and implementation of translational medicine strategies for Oncology compounds  \nApply multiple genomic and biochemical technology platforms to demonstrate target engagement\, develop and implement patient selection and diagnostic strategies.  \nPartner with clinical and discovery groups to create high quality biomarker strategies in the clinic  \nImplement potential novel bioanalytical platforms and introduce new ways to incorporate biomarkers into clinical program designs.  \nDesign and perform experiments to elucidate resistance mechanisms that can be developed into biomarkers and new therapeutics.  \nAuthor the translational research and CDx portions in key clinical documents including protocol/informed consent\, Clinical study Report\, Investigators Brochure\, etc. Contribute the scientific and technical sections as it relates to translational science and CDx in key regulatory documents including INDs\, FDA briefing books\, and submission documents (including NDAs\, IDEs & PMAs).  \nProvide hands-on clinical trial support\, including sample management\, lab work\, and report generation.  \nFunction as an internal expert in oncology biomarkers and precision medicine and actively educate other team members through knowledge sharing.  \nPresent and report data in external meetings and publications.  \nLevel commensurate with experience.  \nQualifications:\nB.S\, M.S. and/or Ph.D. in Cancer Biology\, Cell Biology\, Molecular Biology or related field with 6-8+ (Ph.D)\, 12-14+ (M.S)\, or 14-16+ (B.S) years of experience in developing and implementing translational medicine strategies\, and a track record of success in the pharma industry.  \nStrong scientific background in tumor biology and expertise in immuno-oncology\, epigenetics\, or tumor immune microenvironment is preferred.  \nDemonstrated technical excellence and expertise in Translational medicine; including hands-on experience taking small molecules and/or biologics through preclinical to clinical development.  \nCompanion diagnostics development experience is a plus  \nExperience in analysis of large datasets and knowledge of biostatistics  \nExperience in the development and utilization of biomarkers\, various technologies/platforms ( –omics technologies\, immunohistochemistry and immunoassays\, etc.).  \nEffectively work in a cross-functional team environment\, interacting with various levels within the organization as well as vendors/academic sites/KOLs  \nOrganization\, orientation to details\, and effective time management with an ability to adapt to changing priorities  \nExcellent interpersonal and communication skills.  \nMust be able to work effectively on multiple oncology programs in a fast dynamic environment. 
URL:https://ces.b2sg.org/event/abbvie-21apr18/
LOCATION:AbbVie – Lake County\, IL\, Lake County\, IL\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/11/abbvie-1.jpg
END:VEVENT
END:VCALENDAR